Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada
19 mai 2022 08h30 HE | Isracann Biosciences Inc.
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
Optimi Health Granted Amendment To Controlled Substances Dealer’s Licence
04 mai 2022 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that a requested Amendment...
grapefruit LOGO.png
Grapefruit USA, Inc. California Cannabis Distributor License Renewed in Record Time
25 avr. 2022 06h00 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
grapefruit LOGO.png
Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass™ Time Release THC+CBD Delivery Cream
19 avr. 2022 06h00 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
RYAH logo.jpg
RYAH Secures Health Canada Medical Device License for RYAH Smart Medical Inhaler System
08 mars 2022 07h00 HE | RYAH Group, Inc.
RYAH Smart Medical Inhaler receives Health Canada Medical Device License for Company’s Smart Inhaler SystemCovered by the Health Canada Medical Device License (MDL) include the Inhaler device,...
POC components together-Short Swab
bioLytical Laboratories Inc. Receives Health Canada Authorization for its iStatis COVID-19 Antigen Test
07 mars 2022 09h00 HE | bioLytical Laboratories Inc.
From the makers of INSTI®, bioLytical launches a new platform, iStatis, created to ensure every person in the world has access to reliable testingbioLytical has received Health Canada authorization to...
grapefruit LOGO.png
Grapefruit USA, Inc. Update on Hourglass Health Canada NNCP Submission
03 mars 2022 12h17 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
grapefruit LOGO.png
Grapefruit USA, Inc. Announces Term Sheet with Dubai-Based Lender to Build GPFT ‘Mothership’
16 févr. 2022 06h00 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
grapefruit LOGO.png
Grapefruit USA, Inc. Files Health Canada NNCP Submission 8-K
25 janv. 2022 06h00 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
grapefruit LOGO.png
Grapefruit USA, Inc. Announces NNCP Submission to Health Canada to Enable Canada-Wide Sale of Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream
20 janv. 2022 06h00 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...